NO20002013D0 - Suspensjonsforpakningscellelinjer for retrovirusvektorer - Google Patents

Suspensjonsforpakningscellelinjer for retrovirusvektorer

Info

Publication number
NO20002013D0
NO20002013D0 NO20002013A NO20002013A NO20002013D0 NO 20002013 D0 NO20002013 D0 NO 20002013D0 NO 20002013 A NO20002013 A NO 20002013A NO 20002013 A NO20002013 A NO 20002013A NO 20002013 D0 NO20002013 D0 NO 20002013D0
Authority
NO
Norway
Prior art keywords
cell lines
retroviral vectors
packaging cell
suspension
suspension packaging
Prior art date
Application number
NO20002013A
Other languages
English (en)
Other versions
NO20002013L (no
Inventor
Stefan Seeber
Stefan Koch
Thorsten Gutjahr
Ulrich Steegmans
Ruediger Rueger
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Publication of NO20002013L publication Critical patent/NO20002013L/no
Publication of NO20002013D0 publication Critical patent/NO20002013D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells
    • C12N5/0694—Cells of blood, e.g. leukemia cells, myeloma cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13051—Methods of production or purification of viral material
    • C12N2740/13052—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20002013A 1997-10-25 2000-04-17 Suspensjonsforpakningscellelinjer for retrovirusvektorer NO20002013D0 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP97118583 1997-10-25
EP97121724 1997-12-10
PCT/EP1998/006714 WO1999021967A1 (de) 1997-10-25 1998-10-22 Suspensions-verpackungszellinien für retrovirusvektoren

Publications (2)

Publication Number Publication Date
NO20002013L NO20002013L (no) 2000-04-17
NO20002013D0 true NO20002013D0 (no) 2000-04-17

Family

ID=26145852

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20002013A NO20002013D0 (no) 1997-10-25 2000-04-17 Suspensjonsforpakningscellelinjer for retrovirusvektorer

Country Status (16)

Country Link
EP (1) EP1025207B1 (no)
JP (1) JP3517399B2 (no)
KR (1) KR100359542B1 (no)
CN (1) CN1277631A (no)
AT (1) ATE304048T1 (no)
AU (1) AU729986B2 (no)
BR (1) BR9812960A (no)
CA (1) CA2306634C (no)
DE (1) DE59813048D1 (no)
ES (1) ES2248920T3 (no)
HU (1) HUP0004240A2 (no)
IL (1) IL135541A (no)
NO (1) NO20002013D0 (no)
NZ (1) NZ503827A (no)
TR (1) TR200001125T2 (no)
WO (1) WO1999021967A1 (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100507794B1 (ko) * 2003-02-11 2005-08-17 한미약품 주식회사 고농도 레트로 바이러스 현탁액 제조 방법
EP1739180A1 (en) * 2005-06-27 2007-01-03 Max-Delbrück-Centrum für Molekulare Medizin (MDC) T cell line-based packaging cell line for the production of retroviruses by enriching of CD3 expressing cells
JP5923037B2 (ja) * 2009-06-17 2016-05-24 トカジェン インコーポレーテッド 複製可能レトロウイルスベクターの産生細胞
CN111286517A (zh) * 2018-12-07 2020-06-16 珠海联邦制药股份有限公司 一种复制缺陷型逆转录病毒的包装方法及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4059485A (en) * 1976-11-03 1977-11-22 Monsanto Company Adaptation of cell lines to suspension culture
RU1347448C (ru) * 1985-09-27 1995-04-10 Институт полиомиелита и вирусных энцефалитов Российской АМН Штамм гетероплоидных клеток почки теленка таурус-1, используемый для культивирования вирусов
JPH03505675A (ja) * 1988-10-31 1991-12-12 ザ リージェンツ オブ ザ ユニヴァーシティ オブ カリフォルニア 新生表現型の抑制を制御する産生体及び方法
DE19612966B4 (de) 1996-04-01 2009-12-10 Novartis Vaccines And Diagnostics Gmbh & Co. Kg MDCK-Zellen und Verfahren zur Vermehrung von Influenzaviren

Also Published As

Publication number Publication date
EP1025207A1 (de) 2000-08-09
NO20002013L (no) 2000-04-17
DE59813048D1 (de) 2005-10-13
TR200001125T2 (tr) 2000-09-21
KR20010031387A (ko) 2001-04-16
CN1277631A (zh) 2000-12-20
JP2001520879A (ja) 2001-11-06
AU729986B2 (en) 2001-02-22
IL135541A (en) 2004-02-19
HUP0004240A2 (en) 2001-03-28
KR100359542B1 (ko) 2002-10-31
BR9812960A (pt) 2000-08-08
WO1999021967A1 (de) 1999-05-06
EP1025207B1 (de) 2005-09-07
JP3517399B2 (ja) 2004-04-12
IL135541A0 (en) 2001-05-20
CA2306634C (en) 2005-04-12
ES2248920T3 (es) 2006-03-16
AU1231399A (en) 1999-05-17
ATE304048T1 (de) 2005-09-15
CA2306634A1 (en) 1999-05-06
NZ503827A (en) 2001-06-29

Similar Documents

Publication Publication Date Title
AU2998597A (en) Crossless retroviral vectors
EP1285967A3 (en) Human retroviral packaging cell line
WO1999004026A3 (en) Lentiviral vectors
WO1997007225A3 (en) High efficiency retroviral packaging system
CO4230241A1 (es) COMPUESTOS BICICLICOS UTILES COMO ANTAGONISTAS DE GLICOPROTEINA IIb/IIIa
MY125594A (en) Immortalized cell lines for virus growth
WO1989007136A3 (en) Modified hepatocytes and uses therefor
BR0011489A (pt) Composições formadoras de pelìcula compreendendo amidos modificados e iota-carragenano e processos para a fabricação de cápsulas macias usando as mesmas
MY108663A (en) Liquid detergent compositions containing a suspended peroxygen bleach
ES2128457T5 (es) Metalocenos con puente de sililo y su utilizacion.
PL345561A1 (en) Substituted benzoylcyclohexandiones
DK0700380T3 (da) N-Alkylthiopolyaminderivater som radioprotektive midler
NO20002013D0 (no) Suspensjonsforpakningscellelinjer for retrovirusvektorer
WO2000040741A3 (en) Lentivirus vector system
BG108682A (en) Method for the production of transparent flexible container, and container produced therewith
DK0801575T3 (da) Retrovirale vektorer til ekspression i embryoniske celler
AU6139699A (en) Packaging cell lines for hiv-derived retroviral vector particles
DE69414109D1 (de) Prostaglandin rezeptor ep3 und kodierende dns
DK1097233T3 (da) Promotor for vækstdifferentieringsfaktor og anvendelser deraf
AU5274696A (en) Pseudotyped retroviral particles
DE69716581D1 (de) Retroviraler vektor und dessen verwendung in gentherapie
ES2131036A1 (es) Material de grabacion fotografica en color.
TNSN89009A1 (fr) Utilisation d'inhibiteurs de l'enzyme de conversion de l'angiotensine
AR020076A1 (es) LíNEA CELULAR DE EMPAQUETAMIENTO DE RETROVIRUS ANFOTRoPICO, PROCESO PARA SU PRODUCCIoN, Y PROCESO PARA LA PRODUCCIoN DE UN VECTOR RETROVIRAL MEDIANTE LA MISMA.
ATE264394T1 (de) Klonierung der udp-galaktose-epimerase

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application